Narrow search
Showing 1 - 10 of 35
Cover Image
Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? : a cost-utility analysis alongside a randomized...
Sun, Sun; Jonsson, Håkan; Salén, Klas-Göran; Andén, Mats - In: The European journal of health economics 24 (2023) 2, pp. 237-246
Persistent link: https://www.econbiz.de/10014327971
Cover Image
Does the inclusion of societal costs change the economic evaluations recommendations? : a systematic review for multiple sclerosis disease
Rodríguez-Sánchez, Beatriz; Daugbjerg, S.; … - In: The European journal of health economics 24 (2023) 2, pp. 247-277
Persistent link: https://www.econbiz.de/10014327973
Cover Image
Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity : a systematic review of economic evaluations
Jordan, Karen; Fawsitt, Christopher G.; Carty, Paul G.; … - In: The European journal of health economics 24 (2023) 4, pp. 575-590
Persistent link: https://www.econbiz.de/10014328039
Cover Image
Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions : a comparison of five European countries
Mokri, Hamraz; Kvamme, Ingelin; De Vries, Linda; … - In: The European journal of health economics 24 (2023) 5, pp. 701-715
Persistent link: https://www.econbiz.de/10014328083
Cover Image
Assessing Taiwan's pay-for-performance program for diabetes care : a cost-benefit net value approach
Lu, Jui-fen R.; Chen, Ying Isabel; Eggleston, Karen; … - In: The European journal of health economics 24 (2023) 5, pp. 717-733
Persistent link: https://www.econbiz.de/10014328086
Cover Image
Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study
Hansen, Tonya Moen; Stavem, Knut; Rand, Kim - In: The European journal of health economics 24 (2023) 6, pp. 877-884
Persistent link: https://www.econbiz.de/10014328133
Cover Image
The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK
Viljoen, Adie; Chubb, Barrie; Malkin, Samuel J. P.; … - In: The European journal of health economics 24 (2023) 6, pp. 895-907
Persistent link: https://www.econbiz.de/10014328135
Cover Image
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness : economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries
Li, Xiao; Bilcke, Joke; Velden, Alike Wilhelmina van der; … - In: The European journal of health economics 24 (2023) 6, pp. 909-922
Persistent link: https://www.econbiz.de/10014328147
Cover Image
Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand
Claflin, Suzi; Campbell, Julie A.; Norman, Richard; … - In: The European journal of health economics 24 (2023) 6, pp. 939-950
Persistent link: https://www.econbiz.de/10014328151
Cover Image
The handling of missing data in trial-based economic evaluations : should data be multiply imputed prior to longitudinal linear mixed-model analyses?
Ben, Ângela Jornada; Dongen, Johanna M. van; El Alili, … - In: The European journal of health economics 24 (2023) 6, pp. 951-965
Persistent link: https://www.econbiz.de/10014328152